Japan approves first human milk-based fortifiers as prescription drugs for premature infants.

Regentis Biomaterials expanded its European clinical sites to boost patient recruitment and trial efficiency.

FDA fast-tracks two rapid tests for drug-resistant infections like MRSA and CRE.

Insulet's stock rose after beating Q4 2025 earnings expectations, driven by strong demand for its Omnipod insulin systems and higher revenue.

Brazil and India plan joint drug production to cut costs and boost health security during Lula’s visit.

Merck's RSV antibody showed strong results in young children, supporting extended protection and FDA approval.

India's AYUSH federation seeks a national regulator for Yoga and Naturopathy to standardize education and practice.

The Healthcare Leadership Forum 2026 brings 150+ leaders to Mumbai to address India’s healthcare sector shift toward sustainable growth and profitability.

Jefferies raises Krystal Biotech's price target to $371, citing progress in gene therapy for rare skin diseases.

Aspire Biopharma regained Nasdaq compliance and avoids delisting after meeting equity requirements.